Defunct Company
Total Trials
4
As Lead Sponsor
2
As Collaborator
Total Enrollment
641
NCT01529710
Safety and Efficacy of Mirazid for Schistosomiasis Treatment
Phase: Phase 3
Role: Lead Sponsor
Start: Dec 31, 2011
Completion: Sep 30, 2012
NCT02371408
A Study of the Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4
Phase: Phase 2/3
Start: Jan 31, 2015
Completion: Apr 30, 2016
NCT02985281
Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients
Role: Collaborator
Start: Dec 31, 2016
Completion: Sep 30, 2017
NCT04869579
Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.
Phase: Phase 2
Start: Aug 15, 2021
Completion: Dec 15, 2021